← Back to Clinical Trials
Recruiting NCT06587308

NCT06587308 Effects of Different Pressure Garments on Upper Extremity Sensorimotor Functions and Quality of Life After Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06587308
Status Recruiting
Phase
Sponsor National University of Malaysia
Condition Cerebral Vascular Accident (CVA)/Stroke
Study Type INTERVENTIONAL
Enrollment 165 participants
Start Date 2024-10-08
Primary Completion 2026-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Dorsal-Double-Layered 10% Circumferential Reduction (DD-10) Pressure GarmentSingle-Layered 10% Circumferential Reduction (S-10) Pressure GarmentSingle-Layered No Circumferential Reduction (S-0) Pressure Garment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 165 participants in total. It began in 2024-10-08 with a primary completion date of 2026-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study aims to compare the effects of dorsal-double-layered 10% circumferential reduction (DD-10), single-layered 10% circumferential reduction (S-10), and single-layered no circumferential reduction (S-0) pressure garments on sensorimotor functions, including motor control, dexterity, muscle tone, pain, self-perceived upper extremity function, and quality of life among stroke patients during the 8 weeks of application (Time 1: Baseline, Time 2: Week 4, Time 3: Week 8).

Eligibility Criteria

Inclusion Criteria: * Between 18 and 80 years of age * Within 1-12 months of ischemic or hemorrhagic stroke * First onset resulting in hemiparesis of a limb with Burnnstrom stage of 3, 4 or 5 * Modified Ashworth Scale with scores of less than or equal 2 for elbow, wrist, and hand muscle tone in the affected upper extremity * Able to understand instruction Exclusion Criteria: * Serious cardiovascular or respiratory diseases * Skin lesions, infections or other skin problems * Serious circulatory problems such as deep vein thrombosis * Allergies or significant discomfort to pressure garment materials * Upper extremity fractures or severe joint problems * Severe cognitive impairment with Saint Louis University Mental Status (SLUMs) scores equal to or less than 27 (above high school level of education)/25 (below high school level of education)

Contact & Investigator

Central Contact

Zhenkun Xu, MSc

✉ P126687@siswa.ukm.edu.my

📞 0129838798

Principal Investigator

SIaw Chui Chai, PhD

PRINCIPAL INVESTIGATOR

Occupational Therapy Programme, Centre for Rehabilitation and Special Needs Studies (iCaRehab)

Frequently Asked Questions

Who can join the NCT06587308 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Cerebral Vascular Accident (CVA)/Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06587308 currently recruiting?

Yes, NCT06587308 is actively recruiting participants. Contact the research team at P126687@siswa.ukm.edu.my for enrollment information.

Where is the NCT06587308 trial being conducted?

This trial is being conducted at Weifang, China, Weifang, China, Weifang, China.

Who is sponsoring the NCT06587308 clinical trial?

NCT06587308 is sponsored by National University of Malaysia. The principal investigator is SIaw Chui Chai, PhD at Occupational Therapy Programme, Centre for Rehabilitation and Special Needs Studies (iCaRehab). The trial plans to enroll 165 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology